Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRevention of cArdiac Dysfunction During Adjuvant Breast Cancer Therapy: A Randomized, Placebo-controlled, Multicenter Trial

NCT03760588 is registered in ClinicalTrials.gov with Torbjorn Omland as lead sponsor.

NCT NCT03760588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03760588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRevention of cArdiac Dysfunction During Adjuvant Breast Cancer Therapy: A Randomized, Placebo-controlled, Multicenter Trial
Lead sponsor
Torbjorn Omland
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2019
Completion date
September 5, 2024
Enrollment
138 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, heart failure